Abstract:Background A single administration of the opioid receptor antagonist methocinnamox (MCAM) antagonizes the antinociceptive effects of μ-opioid receptor agonists for 2 weeks or longer. Such a long duration of antagonism could necessitate the use of nonopioid drugs for treating pain in patients receiving MCAM for opioid use disorder (OUD). Methods The antinociceptive effects of fentanyl and nonopioid drugs were assessed in 24 male Sprague Dawley rats using a complete Freund's adjuvant (CFA) model of inflammatory pain. Twelve rats received 10 mg/kg MCAM and 12 received vehicle; half (n=6) of the animals from each treatment group were treated (intraplantar) with CFA or saline. Hypersensitivity to mechanical stimulation was measured using a von Frey anesthesiometer. Fentanyl (0.01-0.1 mg/kg), ketamine (17.8-56 mg/kg), gabapentin (32-100 mg/kg), meloxicam (3.2-10 mg/kg), and ∆ 9 -tetrahydrocannabinol (THC, 1-10 mg/kg) were administered intraperitoneally and tested every 3 days in a pseudorandom order. Next, the same drugs were studied for effects on motor performance using a rotarod apparatus. Results CFA-induced hypersensitivity was attenuated by fentanyl in vehicle- but not MCAM-treated rats. THC, ketamine, and gabapentin attenuated (up to 82, 66, and 46%, respectively) CFA-evoked mechanical hypersensitivity in both MCAM- and vehicle-treated rats. Meloxicam failed to alter CFA-evoked mechanical hypersensitivity in either group. Fentanyl, THC, gabapentin, and meloxicam did not affect motor performance in either group whereas ketamine impaired motor performance in both groups (up to 71% reduction in latency to fall). Conclusions These data suggest that ketamine, gabapentin, and THC could be effective for treating inflammatory pain under conditions of long term μ-opioid receptor antagonism.

Antagonism of ohmefentanyl analgesia by intracerebroventricular injection of adrenocorticotropic hormone in rats

The Role of Opioid in the Mechanism of the Hypotensive Effect by Simulating Acupuncture on Rat Hindlimb

Antagonistic Effect of Orphanin FQ on Opioid Analgesia in Rat

Effect of intracerebroventricular or intrathecal injection of orphanin FQ on pain and acupuncture analgesia in rats

Effects of ohmefentanyl in anesthetic dose on the levels of monoamine transmitters and their metabolites in rat brain

Antinociceptive effects of fentanyl and nonopioid drugs in methocinnamox-treated rats

[Effect of Orphanin FQ on Acupuncture Analgesia and Noxious Stimulation in the Periaqueductal Gray].

Effect of Intrathecal or Intracerebroventricular Administrition of OFQ on Pain Threshold and Acpuncture Analgesia in Rats

Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats.

Involvement of Spinal Orexin A in the Electroacupuncture Analgesia in a Rat Model of Post-Laparotomy Pain

Effects of Orphanin FQ on Endomorphin-1 Induced Analgesia

[Antagonistic Effect of Orphanin FQ on Morphine Analgesia in Rat Brain].

Antinociceptive Role of Oxytocin in the Nucleus Raphe Magnus of Rats, an Involvement of Μ-Opioid Receptor

[Effect of Intrathecal Injection of Dopamine Receptor Agonists/antagonists on Pain and Acupuncture Analgesia in Rats].

Oxytocin in the Periaqueductal Grey Regulates Nociception in the Rat

mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model

Oxytocin in the Periaqueductal Gray Participates in Pain Modulation in the Rat by Influencing Endogenous Opiate Peptides

Intrathecal administration of adrenomedullin induces mechanical allodynia and neurochemical changes in spinal cord and DRG

Role of Opioid Receptor in Nucleus Submedius in Mediating Electroacupuncture Analgesia in Rats

Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.

Effect of Nocistatin in Pain Modulation